MCMCB Pro
J7601

J7601Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg

HCPCSActiveBETOS D1G

J7601 is a HCPCS Level II code for ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J7601 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
2 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J7601

Long descriptor
Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg

The official wording. This is what the code means.

Short descriptor
Ensifentrine inh 3 mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2025

When CMS introduced the code.

BETOS
D1G

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J7601

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J7601 is not quite right, the correct code is very often within a few positions of it.

  • J7518Mycophenolic acid, oral, 180 mg
  • J7519Injection, mycophenolate mofetil, 10 mg
  • J7520Sirolimus, oral, 1 mg
  • J7521Tacrolimus, granules, oral suspension, 0.1 mg
  • J7525Tacrolimus, parenteral, 5 mg
  • J7527Everolimus, oral, 0.25 mg
  • J7528Mycophenolate mofetil, for suspension, oral, 100 mg
  • J7599Immunosuppressive drug, not otherwise classified
  • J7604Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
  • J7605Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
  • J7606Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
  • J7607Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
  • J7608Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
  • J7609Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
  • J7610Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
  • J7611Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg

Questions about J7601

What is HCPCS code J7601?

J7601 is a HCPCS Level II code for ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J7601?

The CMS HCPCS file marks J7601 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J7601 paid under the physician fee schedule?

J7601 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026